Endothelial Dysfunction clinical trials at UC Irvine

1 research study open to eligible people

Showing trials for

  • EndoPAT Device for Endothelial Dysfunction in ED

    open to eligible males ages 18 years and up

    To assess endothelial dysfunction in young men (aged 30-50) with vasculogenic ED identified through penile Doppler ultrasound. To evaluate changes in endothelial function using EndoPAT before and 3-6 months after daily low-dose phosphodiesterase type 5 (PDE5) inhibitor therapy. To investigate endothelial function alterations in hypogonadal patients before and 3-6 months after initiating testosterone (T) therapy

    Newport Beach 5376890, California 5332921

Our lead scientists for Endothelial Dysfunction research studies include .

Last updated: